Susquehanna International Group’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.57M | Buy |
204,014
+129,285
| +173% | +$943K | ﹤0.01% | 6743 |
|
|
2025
Q4 | $458K | Sell |
74,729
-459,256
| -86% | -$4.96M | ﹤0.01% | 8999 |
|
|
2025
Q3 | $9.84M | Buy |
533,985
+411,372
| +336% | +$6.61M | 0.01% | 3064 |
|
|
2025
Q2 | $1.6M | Buy |
122,613
+65,212
| +114% | +$771K | ﹤0.01% | 6280 |
|
|
2025
Q1 | $608K | Buy |
57,401
+2,984
| +5% | +$47.4K | ﹤0.01% | 8474 |
|
|
2024
Q4 | $923K | Buy |
54,417
+15,649
| +40% | +$295K | ﹤0.01% | 7161 |
|
|
2024
Q3 | $900K | Sell |
38,768
-9,842
| -20% | -$211K | ﹤0.01% | 7040 |
|
|
2024
Q2 | $1.18M | Buy |
48,610
+27,183
| +127% | +$824K | ﹤0.01% | 6186 |
|
|
2024
Q1 | $724K | Sell |
21,427
-66,762
| -76% | -$2.37M | ﹤0.01% | 7629 |
|
|
2023
Q4 | $2.78M | Buy |
88,189
+31,876
| +57% | +$758K | ﹤0.01% | 4702 |
|
|
2023
Q3 | $1.44M | Sell |
56,313
-123,180
| -69% | -$3.79M | ﹤0.01% | 5823 |
|
|
2023
Q2 | $5.15M | Buy |
179,493
+125,091
| +230% | +$3.41M | 0.01% | 3481 |
|
|
2023
Q1 | $1.3M | Sell |
54,402
-2,766
| -5% | -$49.6K | ﹤0.01% | 6144 |
|
|
2022
Q4 | $970K | Sell |
57,168
-65,779
| -54% | -$1.15M | ﹤0.01% | 6268 |
|
|
2022
Q3 | $1.82M | Sell |
122,947
-17,755
| -13% | -$298K | ﹤0.01% | 5112 |
|
|
2022
Q2 | $2.21M | Buy |
140,702
+10,200
| +8% | +$200K | ﹤0.01% | 4690 |
|
|
2022
Q1 | $3.52M | Sell |
130,502
-70,292
| -35% | -$1.79M | 0.01% | 4314 |
|
|
2021
Q4 | $7.43M | Buy |
200,794
+57,022
| +40% | +$2.32M | 0.01% | 3116 |
|
|
2021
Q3 | $6.87M | Buy |
143,772
+34,840
| +32% | +$1.56M | 0.01% | 3436 |
|
|
2021
Q2 | $3.69M | Buy |
108,932
+71,702
| +193% | +$2.43M | ﹤0.01% | 4605 |
|
|
2021
Q1 | $1.54M | Sell |
37,230
-126,531
| -77% | -$7.54M | ﹤0.01% | 6579 |
|
|
2020
Q4 | $7.1M | Sell |
163,761
-31,754
| -16% | -$2.15M | 0.01% | 2920 |
|
|
2020
Q3 | $8.39M | Buy |
195,515
+97,053
| +99% | +$4.82M | 0.02% | 2400 |
|
|
2020
Q2 | $4.6M | Sell |
98,462
-31,193
| -24% | -$1.08M | 0.01% | 3115 |
|
|
2020
Q1 | $1.76M | Buy |
129,655
+40,466
| +45% | +$518K | ﹤0.01% | 4194 |
|
|
2019
Q4 | $969K | Sell |
89,189
-2,171
| -2% | -$22.7K | ﹤0.01% | 5602 |
|
|
2019
Q3 | $938K | Buy |
91,360
+50,207
| +122% | +$543K | ﹤0.01% | 5819 |
|
|
2019
Q2 | $388K | Buy |
+41,153
| New | +$302K | ﹤0.01% | 7795 |
|
|
2019
Q1 | – | Sell |
-39,351
| Closed | -$201K | – | 8816 |
|
|
2018
Q4 | $178K | Buy |
39,351
+17,779
| +82% | +$109K | ﹤0.01% | 7844 |
|
|
2018
Q3 | $191K | Sell |
21,572
-4,846
| -18% | -$40.3K | ﹤0.01% | 8253 |
|
|
2018
Q2 | $224K | Buy |
+26,418
| New | +$171K | ﹤0.01% | 8396 |
|
|
2017
Q3 | – | Sell |
-2,572
| Closed | -$19.4K | – | 8806 |
|
|
2017
Q2 | $20K | Sell |
2,572
-1,262
| -33% | -$10.2K | ﹤0.01% | 9019 |
|
|
2017
Q1 | $31K | Sell |
3,834
-4,836
| -56% | -$44.8K | ﹤0.01% | 8664 |
|
|
2016
Q4 | $127K | Sell |
8,670
-4,044
| -32% | -$60.5K | ﹤0.01% | 8957 |
|
|
2016
Q3 | $220K | Buy |
12,714
+702
| +6% | +$22.7K | ﹤0.01% | 7431 |
|
|
2016
Q2 | $378K | Buy |
12,012
+2,408
| +25% | +$75.9K | ﹤0.01% | 6590 |
|
|
2016
Q1 | $255K | Sell |
9,604
-2,222
| -19% | -$75.2K | ﹤0.01% | 7530 |
|
|
2015
Q4 | $520K | Sell |
11,826
-2,002
| -14% | -$90.1K | ﹤0.01% | 6694 |
|
|
2015
Q3 | $585K | Sell |
13,828
-982
| -7% | -$51.7K | ﹤0.01% | 6824 |
|
|
2015
Q2 | $678K | Buy |
14,810
+5,741
| +63% | +$263K | ﹤0.01% | 7019 |
|
|
2015
Q1 | $357K | Sell |
9,069
-12,517
| -58% | -$551K | ﹤0.01% | 7677 |
|
|
2014
Q4 | $564K | Buy |
21,586
+16,561
| +330% | +$527K | ﹤0.01% | 6991 |
|
|
2014
Q3 | $543K | Buy |
+5,025
| New | +$655K | ﹤0.01% | 7044 |
|
Other funds holding ARCT
AIM
NAMA
VCM
VPM
